DEVELOPMENT OF A GENE THERAPY APPROACH FOR THE TREATMENT OF NEUROFIBROMATOSIS TYPE 2

$683,338FY2025Defense Health AgencyDOD

Massachusetts Eye And Ear Infirmary, Boston MA

Investigators

DEVELOPMENT OF A GENE THERAPY APPROACH FOR THE TREATMENT OF NEUROFIBROMATOSIS TYPE 2 · GrantIndex